SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One):   [x] Form 10-K    [ ] Form 20-F   [ ] Form 11-K  [ ]  Form 10-Q

               [ ] Form N-SAR   [ ] Form N-CSR

                       For Period Ended: December 31, 2004

[ ]  Transition Report on Form 10-K          [ ] Transition Report on Form 10-Q
[ ]  Transition Report on Form 20-F          [ ] Transition Report on Form N-SAR
[ ]  Transition Report on Form 11-K

        For the Transition Period Ended:

Read attached instruction sheet before preparing form. Please print or type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:



                                     PART I
                             Registrant Information

Full name of registrant:                   NeoGenomics, Inc.
Former name if applicable:                 American Communications Enterprises, Inc.
Address of Principal Executive Office
(Street and Number):                       12701 Commonwealth Drive, Suite 9
City, state and zip code                   Fort Myers, Florida  34109




                                       1




                                     Part II
                             Rule 12b-25 (b) and (c)

        If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)

[X] (a) The reasons described in reasonable detail in Part III of this form
        could not be eliminated without unreasonable effort or expense;

[X] (b) The subject annual report, semi-annual report, transition report on
        Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
        thereof, will be filed on or before the fifteenth calendar day following
        the prescribed due date; or the subject quarterly report or transition
        report on Form 10-Q, or portion thereof will be filed on or before the
        fifth calendar day following the prescribed due date; and

[ ] (c) The accountant's statement or other exhibit required by Rule
        12b-25(c) has been attached if applicable.




                                       2




                                    PART III
                                    Narrative

        State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, N-SAR, N-CSR, or the transition report portion thereof, could not be filed
within the prescribed time period. (Attach extra sheets if needed.)

        Due to unforeseeable circumstances, which caused a delay in preparing the
financial statements for the year ended December 31, 2004, the Registrant
respectfully requests an extension of the filing date of its Annual Report on
Form 10-KSB for the period ended December 31, 2004.


                                     PART IV
                                Other Information

1. Name and telephone number of person to contact in regard to this
   notification:

     Robert Gasparini            (239)                       768-0600
          (Name)              (Area code)                (Telephone number)

2. Have all other periodic reports required under Section 13 or 15(d) of the
   Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
   of 1940 during the preceding 12 months or for such shorter period that the
   registrant was required to file such report(s) been filed? If the answer is
   no, identify report(s). [X] Yes [ ] No

3. Is it anticipated that any significant change in results of operations from
   the corresponding period for the last fiscal year will be reflected by the
   earnings statements to be included in the subject report or portion
   thereof? [ ] Yes [X] No

   If so: attach an explanation of the anticipated change, both narratively
   and quantitatively, and, if appropriate, state the reasons why a reasonable
   estimate of the results cannot be made.




                                       3







                                NeoGenomics, Inc.
                  (Name of registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:    March 30, 2005                By:/s/ Robert Gasparini
                                          Robert Gasparini, President


                                    ATTENTION
   Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (See 18 U.S.C. 1001).